Finally, anti-SARS-CoV-2 IgA and anti-SARS-CoV-2 IgG levels were similar in JIA patients with active disease (i.e., JADAS 71 > 1) and inactive disease (JADAS 71 ≤ m1), as well as the control group (Table 5). This evidence concerns the gene CD79A and juvenile idiopathic arthritis.